Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan

Similar documents
ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010

Session-1: Template for country presentation (EXISTING Indicators)

End TB Strategy top 10 indicators: current status in participant countries

Annual Scientific conference of Kenya Association of Physicians

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance

Estimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009

TB surveillance. Philippe Glaziou Dubrovnik, May 2009

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE

Investing for Impact

Analysis of the epidemiological impact of tuberculosis in the Republic of Moldova

WHO Global Task Force on TB Impact Measurement An overview

IPT BOTSWANA EXPERIENCE

CIVIL SOCIETY UNGASS TB/HIV COUNTRY REPORT KENYA JANUARY 2010

Estimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana

Background paper number 5

The WHO END-TB Strategy

MEASURING THE LEVEL OF UNDER-REPORTING AND ESTIMATING INCIDENCE FOR TUBERCULOSIS IN VIET NAM

Costing of the Sierra Leone National Strategic Plan for TB

Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Principles and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium

HIV TRENDS UNIVERSAL ACCESS TO HIV TREATMENT IN KENYA

INNOVATIONS IN VMMC SERVICE DELIVERY IN KENYA

The Economic Cost of Non-adherence to TB Medicines Resulting from Stock-outs and Loss to Follow-up in Kenya

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

Monitoring top 10 indicators. Philippe Glaziou September 2016

TB/HIV Project in the Philippines. Yumiko Yanase

Measuring TB incidence, prevalence and mortality: an overview of the recommendations of the WHO Global Task Force on TB Impact Measurement

Post-2015 TB Elimination Strategy and Targets

Finding the missing TB cases

Measuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT

GBD2013 Tuberculosis estimates of mortality, incidence and prevalence

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

TB Data Quality Assurance: United Kingdom

What we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat

Childhood TB and new TB drugs in the WHO European Region

Latest developments in WHO estimates of TB disease burden

TB Disease Prevalence Survey - Overview, why and how

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis

PROGRESS ON IMPLEMENTATION OF THE 3Is IN SOUTH AFRICA. Yogan Pillay Deputy Director General Strategic Health Programmes South Africa

Monitoring and Evaluation

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

The Health Economics and Epidemiology Research Office (HE 2 RO): An overview of research methods and results

Module 2 Mortality CONTENTS ILLUSTRATED GUIDES

ANNEX 5: Estimated Financing Requirements (Continued)

TB Program and Epidemic aka B2B

CHINESE INFORMATION SYSTEM FOR INFECTIOUS DISEASES CONTROL AND PREVENTION. Center for Public Health Surveillance and Information Services, China CDC

The WHO global TB database

Partners for Health Reformplus. Strengthening Health System Responses to HIV/AIDS

2. Are data reliable and complete?

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Assessment of Surveillance data WORKBOOK. Country

Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014

2. Are data reliable and complete?

EXPRESSION OF INTEREST SENSITIZATION OF ADVOCATES ON TB AND HUMAN RIGHTS

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania

How to affect Financial Flows for Population Activities on Primary Level in Turkey

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

January. 12 Components Monitoring and Evaluation System Strengthening Tool

Primary Health Networks

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the

REVISED UPHOLD PERFORMANCE MONITORING PLAN Oct 12 th May

Kenya. Service Provision Assessment Survey Family Planning Key Findings

20 TH APRIL 2012 AT SILVER SPRING HOTEL NAIROBI

Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine

THE BURDEN OF HEALTH AND DISEASE IN SOUTH AFRICA

Assessing the programmatic management of drug-resistant TB

Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya*

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

Malaria Surveillance Bulletin

Policy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Kenya

Globally, it is well documented that certain

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29

Outline. Topic 1 Program Quality and Efficiency (PQE) Overview 2 PQE in Uganda, Kenya and Ghana 3 Next steps

Global reporting system for hepatitis (GRSH) project description

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

IPT Policy Review South Africa. WHO TB/HIV Working Group meeting

UNFPA Dan Okoro. UNICEF Dr Khadija Abdalla

Feedback- Information-Exchange (AFIX) and the Vaccines for Children (VFC) Program to Improve the Quality of Site Visits in New York City

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

Cross-cutting HSS (Health Systems Strengthening): Experience from WPRO

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets

Revised National Tuberculosis Control Programme

Situation of the HIV Epidemic in Cambodia

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes

Contact investigation and prevention in Indonesia

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

South African goals and national policy

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan

Clients perception of HIV/AIDS voluntary counseling and Testing (VCT) services in Nairobi, Kenya

Targeting HIV Settings Through PEPFAR. Bill Coggin, OGAC PEPFAR Laboratory Technical Working Group

Global, National, Regional

RADIO AS A TOOL IN COMMUNITY ENGAGEMENT AND EDUCATION

World Health Organization HIV/TB Facts 2011

Transcription:

Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Accra, Ghana May 1 st 2013 Hillary K. Kipruto on behalf of the Kenya team

System description: Kenya Paper Based R and R system Data flow Feedback Division of Leprosy Tuberculosis and Lung Disease (DLTLD) Aggregate, Analyze, Act Provincial Tuberculosis and Leprosy Coordinator (PTLC) Aggregate, Analyze, Act District Tuberculosis and Leprosy Coordinator (DTLC) Aggregate, Analyze, Act Service Delivery points (TB, HIV, TB/HIV Clinics) Collect Analyze Act NATIONAL 12 REGIONS 270 BMU S 4,325 PHF Transitioning to case-based electronic recording and reporting system TIBU System Data entry at district level (Case based data 2012) Data entry at facility level to follow http://pms.dltld.or.ke Vital registration system still weak and TB mortality Estimates are obtained from WHO Annual reports Efforts to strengthen vital registration systems (ICD-10 in hospitals, verbal autopsy (VR) in community)

Assessment method Using Standards and Benchmark check list developed by WHO Technical review by: Emily Bloss, CDC/DTBE Niki Alami, CDC/DTBE Deanna Tollefson, CDC/DTBE Hillary Kipruto, WHO-Kenya 2-5 th April 2013

RESULTS Data Quality Population Coverage and Civil Registration Special Populations

Data Quality Standard Main findings Result B1.1 Case definitions consistent with WHO guidelines B1.2 TB surveillance system designed to capture a minimum set of variables for reported TB cases B1.3 All scheduled periodic data submissions received and processed at the national level Case definitions are consistent with WHO guidelines -Paper based system: age x sex breakdown only in new cases sm+, sm- and EP; not for re-treatment cases. (Partially met) -Electronic system: (Met) - 896/900 (99.5%) of expected quarterly reports had been received and processed at national level. However, due to some unusual delays because of the elections, the usual annual meeting that is conducted in April to review and finalize reports had not yet been conducted and is planned for end of April, after assessment. MET PARTIALLY MET- Paper System Met-Electronic System PARTIALLY MET

Data Quality (cont.) Standard Main findings Result B1.4 Data in quarterly reports Partiall are accurate, complete, and y met internally consistent (For paper-based systems only) -Based on a review of data from one District and clinic, we found 100% match in number of cases in TIBU quarterly case report, facility register and district registers and patient cards B1.5 Data in national database are accurate, complete, internally consistent, and free of duplicates (For electronic case-based or patient-based systems only) -Data checking for completeness of records: 0 empty records. -Data checking for system missing variables: Data 100% complete for minimum set of variables, except for 1 case missing smear data. -Data checking for duplicates: 2% of cases with duplicate IDs are in system (not yet resolved). -Data checking for inconsistencies: a) -0.05% of cases had age >100 years, b) 0.28% of IDs did not follow correct format, c) 0 cases with date of registration after present date d) 0.005% with date of start treatment after to the date of end treatment Partially met

Data Quality (cont.) Standard Main findings Result B1.6 TB surveillance data are externally consistent 4798 children smears not done + 5338 children with smear +,smear - and EP = 10,136 total cases 10136/98665 = 10.3% MET B1.7 Number of reported TB cases is internally consistent (within country) -No vital registration system with accurate and universal causes of death recorded to measure TB mortality. NOT MET

Internal Consistency: Number of TB Cases Reported # TB Cases 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 Number of reported TB cases by district, Kenya, 2008-2012, Nairobi North (NBNP) Nairobi South (NBSP) Central (CEP) Eastern North (EANP) Eastern South (EASP) Coast (COP) Nyanza North (NYNP) Nyanze South (NYSP) Rift Valley North (RVNP) Rift Valley South (RVSP) Western (WEP) Northeastern (NEP) Refugee 2008 2009 2010 2011 2012

Internal Consistency: Change in TB Cases Reported Percent Change 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% Percent change in reported TB cases by district in Kenya, 2008-2012. % change 2008-2009 % change 2009-2010 % change 2010-2011 % change 2011-2012 -5.0% -10.0% -15.0%

Internal Consistency: % Pulmonary TB Cases No. New TB Cases** 120,000 100,000 80,000 60,000 40,000 20,000 Ratio of Pulmonary to Extrapulmonary TB Cases in Kenya, 2008-2012 84.7% (% Pulmonary) Pulmonary* 82.4% 81.8% 81.8% Extrapulmonary 82.2% 0 2008 2009 2010 2011 2012 *Pulmonary cases include those classified as smear positive, smear negative, and smear not done. **Only new TB cases, retreatment cases not included.

Internal Consistency: % Retreatment Cases Ratio of Retreatment to New TB Cases 120,000 9.5% 9.7% 9.9% 9.6% 100,000 Retreatment New 9.7% Number of TB Cases 80,000 60,000 40,000 20,000 0 2008 2009 2010 2011 2012

Internal Consistency: Gender Ratio Proportion of Male Cases 0.7 0.65 0.6 0.55 0.5 0.45 Ratio of Male to Female TB Cases in Kenya by district, 2008-2012 2008 2009 2010 2011 2012 Nairobi North Nairobi South Central Eastern North Eastern South Coast Nyanza North Nyanze South Rift Valley North Rift Valley South Western North-eastern Refugee *Cases include smear positive, smear negative, and extrapulmonary cases. No smears done and retreatment cases not included.

HIV and TB Trends (C2) 100% HIV Testing and Prevalence among Reported TB Cases, Kenya, 2008-2012 91.4% 83.0% 87.8% 93.4% 94.2% 80% 60% 45.0% 43.7% 41.3% 39.3% HIV Testing Prevalence HIV Prevalence 40% 38.3% 20% 0% 2008 2009 2010* 2011 2012

Population Coverage and Vital Registration Standard Main findings Result B2.1 All diagnosed cases of TB are reported B2.2 Population has good access to health care B3.1 Vital registration system has high national coverage and quality -In Kenya, TB reporting is a legal requirement -No national inventory study conducted for TB cases in last 10 years -Under-5 mortality rate is 73/1000 (WHO, 2009) -46% total health expenditure is out-ofpocket (WHO, 2011) Out-of-pocket expenditure as % of private expenditure on health = 74% (Kenya NHA report, 2011) -Cause of death is documented in 47% of deaths and >10% of deaths have ICD codes Partially met NOT MET NOT MET

Special Populations Standard Main findings Result C1 Surveillance data provide a direct measure of drug resistant TB in new cases C2 Surveillance data provide a direct measure of the prevalence of HIV infection in TB cases C3 Surveillance data for children reported with TB are reliable and accurate OR all diagnosed childhood TB cases are reported -Culture and susceptibility testing only done routinely for high risk groups (re treatment, MDR TB contacts, HCWs), not routinely for new cases -No DRS has yet been conducted -DRS to start soon -In 2012, 92461/98690=94% tested; data of # tested are collected in quarterly reports. -Ratio of age groups 0-4 (n=1336) to 5-14 (n=3981) years is 0.34 (note: This is based on data for cases with sm+, sm-, EP and excludes smears not done because these data are not disaggregated for 0-4 and 5-14 years (smear not done for 4798 children of <15). -No national inventory study conducted for childhood TB cases in last 10 years NOT MET MET NOT MET

Findings: Overview Data Quality Population Coverage Vital Registration Special Populations Out of 7 standards 3 met 2 partially met 2 not met Out of 2 standards 1 not met 1 partially met Out of 1 standard 1 not met Out of 3 standards 1 met 2 not met

Recommendations: Short Term Hire IT staff (2) and epidemiologist (1) to support electronic system (TIBU) and data analysis at national level Perform data audit to assess data quality at national level Conduct surveillance system evaluation as system moves into next phase of roll-out Conduct a national drug resistance survey

Recommendations: Medium Term Assess barriers to health care and previously unreported cases in TB prevalence survey Monitor the level of underreporting through inventory studies Support strengthening of routine vital registration system to ensure accurate causes of (TB) death in community and hospitals (ICD-10) Utilize the information derived from ongoing SARAM in the country

Investment plan Activity Estimated Budget Inventory study to measure the level of under-reporting US$ 250,000 Capacity building for data management and statistical analysis through attending courses and extra staffing at the central level US$257,000 Data Quality assessment US$ 128,000 Evaluation of the Kenyan Surveillance system US$ 30,000 Analysis of available mortality data US$ 7,000 Drug resistance survey US$ 400,000 Delay in Diagnosis survey US$ 56,000 Vital registration Strengthening on reporting of the underlying cause of death USD 600,000*** TB Mortality Survey USD 525,000

Asante!